MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 2 (2005), Issue 3 (March)

1. Tigecycline: clinical evidence and formulary positioning.
   Int J Antimicrob Agents, 25(3): 185-92. [Abstract] [Full-text]
2. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus.
   Pediatrics, 115(3): 642-8. [Abstract] [Full-text]
3. External ocular infections due to methicillin-resistant Staphylococcus aureus (MRSA).
   Eye, 19(3): 284-91. [Abstract] [Full-text]
4. Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus.
   J Antimicrob Chemother, 55(3): 379-82. [Abstract] [Full-text]
5. Linezolid in the treatment of Gram-positive prosthetic joint infections.
   J Antimicrob Chemother, 55(3): 387-90. [Abstract] [Full-text]
6. Rapid identification of staphylococcal strains from positive-testing blood culture bottles by internal transcribed spacer PCR followed by microchip gel electrophoresis.
   J Clin Microbiol, 43(3): 1149-57. [Abstract] [Full-text]
7. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis.
   J Cyst Fibros, 4(1): 49-52. [Abstract] [Full-text]
8. Prospective evaluation of emerging bacteria in cystic fibrosis.
   J Cyst Fibros, 4(1): 41-8. [Abstract] [Full-text]
9. Dehydroepiandosterone induction of increased resistance to vancomycin in Staphylococcus aureus clinical isolates (MSSA, MRSA).
   Lett Appl Microbiol, 40(4): 249-54. [Abstract] [Full-text]
10. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
    Pharmacotherapy, 25(2): 253-64. [Abstract] [Full-text]
11. Community-associated methicillin-resistant Staphylococcus aureus: a review.
    Pharmacotherapy, 25(1): 74-85. [Abstract] [Full-text]
12. Nosocomial infection caused by methicillin-resistant Staphylococcus aureus in Palestine.
    Microb Drug Resist, 11(1): 75-7. [Abstract] [Full-text]
13. Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus isolated at a Turkish university hospital.
    Microb Drug Resist, 11(1): 48-52. [Abstract] [Full-text]
14. Recently published papers: from superbugs to superbowl.
    Crit Care, 9(2): 131-3. [Abstract] [Full-text]
15. Staphylococcus aureus carriage among participants at the 13th European Congress of Clinical Microbiology and Infectious Diseases.
    Eur J Clin Microbiol Infect Dis, 24(2): 145-8. [Abstract] [Full-text]
16. Ventriculitis due to a hetero strain of vancomycin intermediate Staphylococcus aureus (hVISA): successful treatment with linezolid in combination with intraventricular vancomycin.
    J Infect, 50(3): 252-7. [Abstract] [Full-text]
17. In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci.
    Ann Clin Microbiol Antimicrob, 4(1): 2. [Abstract] [Full-text]
18. Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175).
    J Antimicrob Chemother, 55(4): 579-82. [Abstract] [Full-text]
19. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.
    Biomaterials, 26(25): 5251-8. [Abstract] [Full-text]
20. Revised structures for the capsular polysaccharides from Staphylococcus aureus Types 5 and 8, components of novel glycoconjugate vaccines.
    Carbohydr Res, 340(6): 1097-106. [Abstract] [Full-text]

© 2004-2008 MRSA Research Today. All Rights Reserved.